Cargando…
A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882717/ https://www.ncbi.nlm.nih.gov/pubmed/35228518 http://dx.doi.org/10.1038/s41392-022-00909-z |
| _version_ | 1784659754431283200 |
|---|---|
| author | Duan, Fugang Wang, Yifan Chen, Taoyu Zhu, Zhu Yu, Meng Dai, Hui Zheng, Shangen Lu, Yinying Li, Tingting Qiu, Xiaoyan |
| author_facet | Duan, Fugang Wang, Yifan Chen, Taoyu Zhu, Zhu Yu, Meng Dai, Hui Zheng, Shangen Lu, Yinying Li, Tingting Qiu, Xiaoyan |
| author_sort | Duan, Fugang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8882717 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88827172022-02-28 A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex Duan, Fugang Wang, Yifan Chen, Taoyu Zhu, Zhu Yu, Meng Dai, Hui Zheng, Shangen Lu, Yinying Li, Tingting Qiu, Xiaoyan Signal Transduct Target Ther Letter Nature Publishing Group UK 2022-02-28 /pmc/articles/PMC8882717/ /pubmed/35228518 http://dx.doi.org/10.1038/s41392-022-00909-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Duan, Fugang Wang, Yifan Chen, Taoyu Zhu, Zhu Yu, Meng Dai, Hui Zheng, Shangen Lu, Yinying Li, Tingting Qiu, Xiaoyan A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex |
| title | A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex |
| title_full | A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex |
| title_fullStr | A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex |
| title_full_unstemmed | A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex |
| title_short | A novel strategy for identifying biomarker in serum of patient with COVID-19 using immune complex |
| title_sort | novel strategy for identifying biomarker in serum of patient with covid-19 using immune complex |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882717/ https://www.ncbi.nlm.nih.gov/pubmed/35228518 http://dx.doi.org/10.1038/s41392-022-00909-z |
| work_keys_str_mv | AT duanfugang anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT wangyifan anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT chentaoyu anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT zhuzhu anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT yumeng anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT daihui anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT zhengshangen anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT luyinying anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT litingting anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT qiuxiaoyan anovelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT duanfugang novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT wangyifan novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT chentaoyu novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT zhuzhu novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT yumeng novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT daihui novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT zhengshangen novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT luyinying novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT litingting novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex AT qiuxiaoyan novelstrategyforidentifyingbiomarkerinserumofpatientwithcovid19usingimmunecomplex |